Alwin Capital

Venture Capital China ·Founded 2015

Overview

Alwin Capital is a Chinese venture capital firm specializing in early-stage life science investments. Founded in 2015 by former senior executives from China International Capital Corporation (CICC), the firm leverages decades of experience in healthcare research and medical markets to identify and support innovative companies in the life sciences sector. Alwin Capital manages both RMB and USD funds, with assets under management totaling approximately $500 million, and has invested in numerous life science companies, cultivating leading firms in their respective segments. The firm's investment strategy is driven by theme-focused research in life sciences, aiming to capture outstanding opportunities for innovative diagnostic and therapeutic developments. Alwin Capital focuses on sectors such as gene editing, nucleic acid drugs, cell therapy, and molecular diagnostics, as well as interdisciplinary areas combining innovative technology and life sciences. The firm is committed to long-term investments, seeking to generate superior returns based on scientific insights. Alwin Capital's portfolio includes a diverse range of companies across the life sciences spectrum. The firm has developed a competitive advantage in China's medical industry, encompassing deal sourcing, portfolio construction, and post-investment empowerment. This approach has enabled Alwin Capital to establish itself as a professional and focused investment force in the field of life sciences in China.

Investment Focus

  • Focus on early-stage life science companies
  • Interest in innovative diagnostic and therapeutic developments
  • Commitment to long-term investments based on scientific insights

Portfolio Companies

EdiGene

Reach Alwin Capital directly

Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.

Unlock full contacts →

Frequently asked questions about Alwin Capital

What sectors does Alwin Capital invest in?

Alwin Capital invests in Healthcare, Artificial Intelligence, Life Sciences, Healthcare Services, Pharmaceuticals and Medical Devices, and is based in China. Alwin Capital is listed as a venture capital in the ConnectSafely investor database.

What stage does Alwin Capital invest at?

Alwin Capital backs companies at Seed.

Which regions does Alwin Capital invest in?

Alwin Capital invests across China.

What companies has Alwin Capital invested in?

Alwin Capital's portfolio includes EdiGene.

Last updated · Source: ConnectSafely investor database